Introduction
Recently, interest in myocardial innervation imaging using 186) or SPECT (187, 188) has increased based on its potential to predict life threatening arrythmias (60, 190, 191) . Sympathetic nerve terminals are more vulnerable to ischemic damage than cardiomyocytes and, consequently, in myocardial infarctions, the region of reduced myocardial innervation often exceeds that of scar formation (mismatch) (60, 191, 193, 194) . In a preclinical study (58), this mismatch area was shown to be a predictor of inducible ventricular tachycardias, originating from these mismatch areas. Therefore, noninvasive imaging of myocardial innervation may play a major role in risk stratification and treatment planning for patients with (ischemic) heart failure.
Myocardial innervation can be measured using [ 11 C]-meta-hydroxyephedrine ([ 11 C]HED) (182, 186) . [ 11 C]HED kinetics can be quantified (201, 202) with the single tissue compartment model being the most robust method (Chapter 7 of this thesis), which potentially yields more accurate and clinically more relevant information than qualitative analysis. To date, however, quantitative [
11 C]HED studies require arterial blood sampling for measuring the metabolite corrected arterial plasma input function. This, in turn, requires arterial cannulation, which is a burden to the patient and technically demanding. Therefore, arterial blood sampling is less suitable for routine clinical applications and alternatives should be explored.
Especially for cardiac studies, an alternative for arterial sampling is the use of an image derived input function (IDIF), as large blood pool structures (e.g. ascending aorta, aortic arch, left ventricle, left atrium) are in the field of view of the scanner. IDIFs (117, 150) . In case of [ 11 C]HED a complexity is the very rapid clearance from the blood in combination with high specific uptake in myocardial tissue, which essentially makes the large blood pool structures cold spots within the scan at late time points. For this reason, significant spillover from surrounding tissues and even small errors in scatter corrections can have large consequences for IDIF and results obtained with other tracers cannot directly be extrapolated to [
11 C]HED. In addition, as [
11 C]HED has significant metabolism within the study duration (Chapter 7 of this thesis), input functions need to be corrected for plasma to blood ratios and presence of radiolabelled metabolites. Large inter-subject differences in rate of [
11 C]HED metabolism have been observed and, consequently, individual metabolite corrections are required. In theory, corrections for metabolites can be derived from venous samples, but evidence is emerging that there may be discrepancies between metabolite corrections obtained using arterial and venous blood for at least some tracers (64). Therefore, the aim of the present study was to assess whether [
11 C]HED kinetics can be quantified reliably without arterial cannulation, using an IDIF and venous blood samples.
Materials and methods

Patient population
20 patients (mean age 69 years, range 50-82, 15 males) with ischemic or dilated cardiomyopathy and a left ventricular ejection fraction below 35%, as determined by cardiac magnetic resonance imaging (MRI), were included in the study. Ischemic cardiomyopathy was defined as the presence of one or more stenoses > 50% on coronary angiography and delayed contrast enhancement on cardiac MRI. The study was approved by the Medical Ethics Review Committee of the VU University Medical Center and all participants gave written informed consent prior to inclusion.
Scanning protocol
[ 11 C]HED was synthesized as described previously (Chapter 7 of this thesis). Studies were performed on a Gemini TF-64 PET/CT scanner (Philips Healthcare, Best, The Netherlands) (66). A 60 minutes dynamic emission scan was started simultaneously with the injection of 370 MBq [
11 C]HED, administered as a 5 mL bolus (0.8 mL⋅s -1 ) followed by a 35 mL saline flush (2 mL⋅s -1 ). This emission scan was followed immediately by a respiration averaged low-dose CT (LD-CT) scan (55 mAs, rotation time 1.5 s, pitch 0.825, collimation 64x0.625, acquiring 20 cm in 12 s compared with 5 s for a regular LD-CT) during normal breathing. Images were reconstructed into 36 frames (1 x 10, 8 x 5, 4 x 10, 3 x 20, 5 x 30, 5 x 60, 4 x 150, 4 x 300, 2 x 600 s), applying all appropriate corrections for scanner normalization, scatter, dead time, decay, randoms and attenuation based on the LD-CT scan. All data were reconstructed in three different ways. The first reconstruction was performed using the standard 3D row action maximum likelihood algorithm (3D-RAMLA) reconstruction protocol with standard scatter correction (3DR STD ). The second was performed using the same standard 3D-RAMLA reconstruction protocol, but this time with Monte Carlo based scatter correction (210) (3DR MC ). The final reconstruction was performed using the standard time of flight (TF) reconstruction protocol, which only comes with Monte Carlo based scatter correction (66, 210).
Input functions
All patients received an indwelling radial artery catheter for arterial blood sampling during the dynamic emission scan. Using an online detection system (204) arterial blood was withdrawn continuously at a rate of 5 mL⋅min -1 during the first 5 min and 1.7 mL⋅min -1 thereafter. In addition, 7 mL arterial blood samples were collected manually at 2. 5, 5, 10, 15, 20, 30, 40 and 60 min post-injection. For 13 patients, 7 mL venous blood samples were collected from the infusion line, simultaneously with the arterial blood samples. Activity concentrations in plasma and whole blood were determined for each sample. In addition, plasma was analysed for radiolabelled metabolites of [ 11 C]HED by Solid Phase Extraction (SPE) as described previously (Chapter 7 of this thesis).
Blood sampler data were corrected for delay and dispersion by fitting the early part of the sampler curve to the ascending aorta (AA) time-activity curve (TAC) as described previously (Chapter 7 of this thesis). This curve was obtained by drawing 1 cm diameter circular regions of interest (ROIs) over the ascending aorta in 5 transaxial images of an early frame of the dynamic scan, i.e. the frame in which the first-pass of the bolus through the AA was best visible (96). ROIs were placed in the centre of the ascending aorta to limit partial volume effects. In addition, to avoid spill-over from the myocardium, these ROIs were drawn in the planes furthest from the myocardium but before the aortic arch, leaving out the top 5 planes from the edge of the FOV to avoid low counting statistics. These ROIs were combined into a single AA VOI, which was transferred to the dynamic image sequences to extract the AA TAC. Next, the resulting delay corrected sampler curve was calibrated using the manually drawn blood samples. Plasma to whole blood ratios derived from the arterial blood samples were fitted to a sigmoid function. Similarly, parent fractions derived from the same samples were also fitted to a sigmoid function (206). Finally, the plasma blood sampler input function (BSIF) C P (t) was obtained by multiplying the delay and dispersion corrected and calibrated blood TAC with both these sigmoid functions. An IDIF was obtained by multiplying the AA TAC, obtained for each separate reconstruction, with the same sigmoid functions.
Venous blood samples were handled in the same way as arterial samples and the resulting sigmoid functions (for plasma to whole blood ratios and for parent fractions) were then applied to the AA TAC to obtain an alternative IDIF. In addition, for both plasma to whole blood ratios and for parent fractions, transformation factors from venous to arterial values were derived, using an empirically derived 2 nd degree polynomial. These transformation factors were then applied to the raw data of the venous blood and these transformed data were fitted using sigmoid functions as described above. Finally, these sigmoid functions were applied to the AA TAC in order to get a third IDIF, based on transformed venous blood data.
To correct for spill-over from the right ventricle (RV), a set of ROIs was placed over the RV cavity in 5 consecutive transaxial planes, with ROI boundaries at least 1 cm away from the RV wall to avoid spill-over of myocardial activity. These ROIs were combined in a single RV VOI, which was then transferred to the full dynamic image sequence to obtain the right ventricular time-activity curve (C RV (t)). For all reconstructions, the same set of VOIs for both AA and RV VOIs was used.
Quantification of [ 11 C]HED kinetics
Using software developed in-house within Matlab 7 (Mathworks, Natick, MA, USA), 16 myocardial segment VOIs were drawn on the final frame of the dynamic (3DR STD ) scan according to the 17-segment model of the American Heart Association (169), excluding apex as this segment could not be delineated re- liably in a large subset of the patients. This VOI template was projected onto the entire dynamic emission scan to extract segmental TACs. Segmental TACs were fitted to a single tissue compartment model (1T2k) using non-linear least squares. Corrections for spill-over from left and right ventricles were included in the following model:
C PET (t), C A (t) and C RV (t) represent measured activity concentrations, and arterial blood and right ventricular blood concentrations, respectively, C P (t) plasma activity concentrations of parent [
11 C]HED, K 1 influx rate of [ 11 C]HED and k 2 the clearance rate of [
11 C]HED. V A was assumed to be spill-over instead of arterial blood volume, as this implementation provides more accurate and robust parameter estimates (Chapter 7 of this thesis). In addition, V RV was considered to be spill-over only since this parameter only corrects for spillover during the first pass of the bolus through the right ventricular cavity and not for actual venous blood volume. The total volume of distribution V T was defined as K 1 /k 2 . Segmental TACs were fitted using non-linear least squares and standard weighing factors. To exclude outliers or unreliable fits, only segments with parameters estimates with a coefficient of variation less than 25% were included. To eliminate differences in VOI definition, a single VOI template was used for all reconstructions.
Data analysis
Area under the curve (AUC) was obtained for both whole BSIF and IDIF curves (AUC 0-60 ), and for early (0-1 minute post injection, AUC 0-1 ) and late (20-60 minutes post injection, AUC 20-60 ) time intervals separately. AUC were compared using paired Wilcoxon rank tests. Correlations between BSIF and IDIF derived K 1 and V T , and between arterial and venous data, were assessed using linear regression with zero intercept. Transformation factors for venous data were validated by a direct comparison of K 1 and V T values derived using arterial data and (transformed) venous data. In addition, to validate consistency of these transformation factors, patients were split in two subgroups and for each group, transformation factors were derived and applied to the data of the other subgroup. Resulting K 1 and V T values were compared with those derived using arterial data.
Results
Validation of IDIF
For three patients, online blood sampling failed due to technical reasons and these patients were excluded for the comparison between BSIF and IDIF. Typical examples of BSIF and IDIF data are shown in Figure 8 .1 showing the first pass of the bolus through the left ventricle (A) and late activity concentrations (B). In general, IDIF AUC 0-60 was significantly overestimated for TF (p = 0.033) as compared to BSIF AUC 0-60 . No significant differences between IDIF and BSIF were found for both 3DR STD and 3DR MC (p = 0.856 and p = 0.435). Similar results were obtained for AUC 20-60 (p = 0.356, p = 0.201 and p < 0.001 for 3DR STD , 3DR MC and TF, respectively). AUC 0-1 was significantly different for all reconstructions (p = 0.008, p = 0.004 and p < 0.001 for 3DR STD , 3DR MC and TF, respectively). Because of the significant differences between IDIF and BSIF, especially for the tail of the curve, TF was discarded from further analyses. 
Validation of venous blood samples
For one patient, venous samples could not be measured reliably due to technical reasons. For the remaining 12 patients, average arterial and venous plasma to whole blood ratio and parent fraction and their ratios are shown in Figure  8 .4. As can be seen, for both plasma to whole blood ratio and parent fraction, arterial and venous data differ significantly. Figure 8 .5 shows fitted plasma to whole blood ratio and parent fraction for venous versus arterial data for all patients. As can be seen, there is a clear but non-linear relationship between both data sets. A 2 nd degree polynomial with free intercept for plasma to whole blood ratio and intercept forced to 0 for parent fraction was used to transform venous data based on the entire population and both subgroups. For the entire population, transformation factors were as follows: In which PBR is plasma to whole blood ratio and PF is parent fraction. Figure  8 .6 shows correlation plots of K 1 and V T for non-transformed and transformed venous data using the transformation factors of Eqs. 8.2 and 8.3, i.e. including all patients. As can be seen, K 1 is estimated accurately for both venous and transformed venous data (r 2 = 0.99, r 2 = 0.99 and slope = 1.00, slope = 0.98 for venous and transformed data, respectively). In contrast, V T was estimated with a significant bias when venous data were used (r 2 = 0.96, slope = 0.84). Using transformed data, no significant bias was observed (r 2 = 0.97, slope = 0.97). For both transformed and non-transformed data, bias was consistent as indicated by the high correlations observed.
No significant differences were found in the parameters of the transformation factors when patients were split in 2 subgroups. When transformation factors of subgroup 1 were applied to data of subgroup 2 and vice versa, for both K 1 and V T , similar results were obtained as for the transformation factors based on data of all patients (r 2 = 0.99, slope = 1.02 for group 1 and r 2 = 1.00, slope = 0.96 for group 2 for K 1 ; r 2 = 0.98, slope = 0.98 for group 1 and r 2 = 0.95, slope = 0.98 for group 2 for V T , none of the slopes significantly different from unity).
Discussion
In the present study, an alternative to invasive (online) arterial blood sampling for quantification of [
11 C]HED kinetics, i.e. the use of an image derived input function (IDIF) in combination with venous blood samples, was assessed. Large differences in blood and tissue activity concentrations during the first pass of the bolus through the left ventricle and, again, at late time points make accurate Figure 8 .5. Correction factors for plasma to whole blood ratio (red dots) and parent fraction (blue dots) derived from arterial (horizontal axis) and venous (vertical axis) blood data. Lines indicate fits derived using a second order polynomial, of which the inverse was used to transform venous data into arterial data (equations 8.2 and 8.3).
corrections for scattered coincidences essential when using an IDIF. Accurate IDIFs could be obtained using 3D-RAMLA reconstructions with Monte Carlo based scatter corrections and to a lesser extent with standard scatter corrections. However, time of flight reconstructions showed large bias in measured blood activity concentrations. This bias showed no relation with activity in the high uptake liver (r 2 = 0.005, p = 0.815) or with the fraction of the liver in the field of view, suggesting that scatter is not the main cause of this bias. In addition, when frame lengths were increased, bias remained, which suggests that this bias was not introduced by noise (i.e. low count rates).
With the model implementation used in this study, IDIF resulted in no bias for V T and a small, but consistent, bias for K 1 when results were compared with those obtained using a BSIF. In addition, when venous blood samples were used to correct for both plasma to blood ratios and radiolabeled metabolites, a large but consistent bias was seen in V T but not in K 1 . This bias in V T was no longer significant when transformation factors were applied to venous blood data and K 1 could still be calculated with no bias when transformation factors were applied.
Bias in K 1 when using IDIF is expected to be caused by a slight but significant overestimation of blood activity in the early phase (area under the curves for the first minute post injection) when using IDIF as compared to BSIF, which was assumed to be a gold standard. At present, the reasons for the observed difference in early blood activities between IDIF and BSIF remain unclear. Small errors in delay and/or dispersion correction of BSIF are not expected to introduce a difference in total activity (i.e. area under curve, AUC). In addition, the injected dose was chosen to remain well within the linear range of the scanner in which dead time corrections are still reliable, the upper limit of which is at a singles count rate of about 35 Mcps (153). Although scatter corrections were shown to yield accurate estimates of activity in a cold spot within a region with high activity, residual inaccuracies in absolute scaling of scatter corrections during the first pass, where all activity is present in a small volume, cannot be Figure 8 .6. Correlation plots for K 1 (A) and V T (B) calculated using venous (red) and transformed venous (blue) data versus K 1 and V T , respectively, calculated using arterial data. Transformation factors were derived using a 2 nd degree polynomial function of which the parameters were obtained from all patients. Solid lines represent linear fits whilst the black dashed line depicts the line of identity.
excluded as underlying cause. Similar discrepancies were found in other studies that performed absolute quantification of [
11 C]HED kinetics (201, 202) . These studies used a combination of blood sampler and image derived data, using the left atrium, as IDIF data suffered from increased spill-over during late time points and BSIF data suffered from a significant apparent loss of [
11 C]HED during early time points (201). This is similar to results of the current study for early activity, showing a discrepancy in early activity between BSIF and IDIF data although it is unclear whether this is an apparent loss in BSIF activity, or an overestimation in IDIF activity. Since the current study made use of the ascending aorta rather than the left atrium for definition of IDIF, spill-over was not an issue which is in line with results obtained with FDG (150).
In this study, arterial activity was assumed to be spill-over from the arterial blood pool, rather than activity originating from an arterial blood volume fraction in the tissue. Both assumptions are physiologically not fully correct and, ideally, a combination should be used. However, differentiating between contributions from spill-over and myocardial blood volume is impossible, as kinetics of both contributions are identical. A recent study (Chapter 7 of this thesis) showed that more accurate and precise results were obtained when arterial activity was assumed to be spill-over and therefore, this implementation was used. In addition, when arterial activity was assumed to be due to activity in an arterial blood volume fraction originating from within myocardial tissue, a bias in IDIF results was observed (data not shown). An overestimation in total supply of radiotracer in IDIF, as compared to BSIF, leads to an underestimation of K 1 which is consistent with results observed in this study.
Accurate measurement of arterial whole blood concentrations from a vascular ROI is a necessary condition for the use of an IDIF. It is, however, not sufficient, as the input function should be a metabolite corrected plasma input function and additional blood sample data are required. The gold standard approach to obtain such a plasma input function is to use plasma to whole blood ratio and parent fraction data from arterial blood samples. In the present study, using data from venous blood samples had no significant effect on derived K 1 values, as indicated by the excellent correlation and slope of the linear fit between K 1 values derived from arterial and venous blood samples. In contrast, it introduced a large bias in V T values, as indicated by a slope of the linear fit of 0.84, which was significantly different from unity. This is not unexpected as K 1 is estimated from the early phase of the scan, during which metabolism has no significant effect and plasma to blood ratios are similar. In addition, differences between arterial and venous data are small (Figure 8 .4B) in the early phase of the scan. In contrast, V T is estimated from the late phase of the scan in which metabolism is significant and differences in arterial and venous data are more pronounced (Figure 8 .4B). Given that in most cases V T will be the most important [
11 C]HED parameter, data from venous samples cannot be used. Therefore, an attempt was made to transform venous data into data representing arterial data using an empirical transformation based on 2 nd order polynomials to fit both venous plasma to whole blood ratio and parent fraction data to corresponding arterial data (Figure 8.5 ). This transformation resulted in no significant bias in V T or K 1 . To illustrate consistency of these transformation factors, patients were split in two subgroups of six patients each and transformation factors were derived for each subgroup and then applied to the other subgroup. No significant differences in correlation or slopes of the linear fits were found between both subgroups and the entire patient population.
Conclusion
IDIF yielded accurate results, but only for 3D-RAMLA reconstructed images with best results obtained using Monte Carlo based scatter corrections. In addition, venous blood samples can be used for absolute quantification of [ 11 C]HED kinetics, provided that a venous-to-arterial transformation is applied. This suggests that for patients with ischemic or dilated cardiomyopathy, absolute quantification of [
11 C]HED kinetics can be performed non-invasively.
